When CYP24A1 activity is marginal or lacking in humans a detrimental hypercalcemia occurs with coincidently low 24,25 (OH)2D3 and high 25 (OH)D3 concentrations in plasma (34). This evidence concerns the gene CYP24A1 and hypercalcemia disease.